7
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Differential Sensitivity to Interleukins of CDS and CDS Anti-Dna Antibody-Producing B Cells in Murine Lupus

, , , &
Pages 205-214 | Received 10 Apr 1992, Accepted 26 Oct 1992, Published online: 07 Jul 2009

References

  • Howie J B, Helyer B J. The immunology and pathology of NZB mice. Adv Immunol 1968; 9: 215–266
  • Shirai T, Hirose S, Okada T, Nishimura H. Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains. Immuno-logical Disorders in Mice, V Rihováb, Vetvicka. CRC Press, Boca Raton, Florida 1991; 95–136
  • Kohno A, Yoshida H, Sekita K, Maruyama N, Ozaki S, Hirose S, Shirai T. Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB×NZW) FI hybrid. Immunogenerics 1983; 18: 513–524
  • Steward M W, Hay F C. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in NZB/W F1 hybrid mice. CIin Exp Immunol 1976; 261: 363–370
  • Papoian R, Pillari'setty R, Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZBNZW FI mice. Immunology 1977; 32: 75–79
  • Shirai T, Hirose S, Sekigawa I, Okada T, Sato H. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice. J Rheumatol 1987; 14: 11–20, SUPPI. 13
  • Finkelman F D, Holmes J, Katona I M, Urban J F, Jr., Beckmann M P, Park L S, Schooley K A, Coffman R L, Mosmann T R, Paul W E. Lymphokine control of in vitro immunoglobulin isotype selection. Ann Rev Immunol 1990; 8: 303–333
  • Umland S P, Go N F, Cupp J E, Howard M. Responses of B cells from autoimmune mice to IL-5. J Immunol 1989; 142: 1528–1535
  • Hitoshi Y, Yamaguchi N, Mita S, Sonoda E, Takaki S, Tominaga A, Takatsu K. Distribution of IL-5 receptor-positive B cells: expression of IL-5 receptor on Ly-I(CD5)+ B cells. J Immunol 1990; 144: 4218–4225
  • Herzenberg L A, Stall A M, Lalor P A, Sidman C, Moore W A, Parks D R, Herzenberg L A. The Ly-1 B cell lineage. Immunol Rev 1986; 93: 81–102
  • Abe M, Okada T, Matsumoto K, Ishida Y, Shiota J, Nishimura H, Hirose S, Sato H, Shirai T. The novel murine B cell differentiation antigen Lp-3. Int Immunol 1989; 1: 576–581
  • Sekigawa I, Noguchi K, Hasegawa K, Hirose S, Sato H, Shirai T. B cell hyperresponsiveness to interleukin 2 and the age-associated decline in murine lupus. Clin Immunol Immunopathol 1989; 51: 172–184
  • Lehmann K R, Kotzin B L, Portanova J P, Santoro T I. Interleukin 2 is a proliferative signal for B cells from autoimmune mice. Eur J Immunol 1986; 16: 1105–1110
  • Sekigawa I, Ishida Y, Hirose S, Sato H, Shirai T. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB×NZW) F1 hybrid. J Immunol 1986; 136: 1247–1252
  • Sekigawa I, Okada T, Noguchi K, Ueda G, Hirose S, Sato H, Shirai T. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB×NZW) FI hybrid mice. J Immunol 1987; 138: 2890–2895
  • Okada T, Abe M, Takiura F, Hirose S, Shirai T. Distinct surface phenotypes of B cells responsible for spontaneous production of IgM and IgG anti-DNA antibodies in autoimmune-prone NZB×NZW FI mice. Autoimmunity 1990; 7: 109–120
  • Hasegawa K, Abe M, Okada T, Hirose S, Sato H, Shirai T. Are Lyl B cells responsible for the IL2-hyperresponsiveness of B cells in autoimmune-prone NZB×NZW FI mice?. Int Immunol 1989; 1: 99–103
  • Hardy R R, Hayakawa K. Development and physiology of Ly-1 B and its human homolog,- Leu-I B. Immunol Rev 1986; 93: 53–79
  • Kocks C, Rajewsky K. Stable expression and somatic hyper-mutation of antibody V regions in B-cell developmental pathways. Ann Rev Immunol 1989; 7: 537–559
  • Casali P, Notkins A L. Probing the human B-cell repertoire with EBV: Polyreactive antibodies and CD5′ B lymphocytes. Ann Rev Immunol 1989; 7: 513–535
  • Casali P, Notkins A L. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10: 364–368
  • Hayakawa K, Hardy R R, Parks D R, Henenberg L A. The “Ly-I B” cell subpopulation in normal, immunodefective, and autoimmune mice. J Exp Med 1983; 157: 202–218
  • Hayakawa K, Hardy R R, Honda M, Herzenberg L A, Steinberg A D, Herzenberg L A. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984; 81: 2494–2498
  • Shirai T, Hirose S, Okada T, Nishimura H. CD5+ B cells in autoimmune disease and lymphoid malignancy. Clin Immunol Immunopathol 1991; 59: 173–186
  • Shirai T, Okada T, Hirose S. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann NY Acad Sci 1992; 651: 509–526
  • Forster I, Rajewsky K. Expansion and functional activity of Ly-I+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J. Immunol 1987; 17: 521–528
  • Harada N, Kikuchi Y, Torninaga A, Takaki S, Takatsu K. BCGF II activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J Immunol 1986; 134: 3944–3951
  • Shiota J, Nishimura H, Okamoto H, Hattori S, Abe M, Okada T, Nozawa S, Hirose S, Shirai T. A novel murine differentiation antigen Lp-3 expressed on anti-DNA antibody producing B cells is leukosialin (CD43). Proc Jap Soc Immunol 1991; 21: 508, (Abstract in Japanese)
  • Kincade P W, Lee G, Sun L, Watanabe T. Monoclonal rat antibodies to murine IgM determinants. J Immunol Merhods 1981; 42: 17–26
  • Ledbetter J A, Herzenberg L A. Xenogeneic monoclonal anti-bodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63–90
  • Dialynas D P, Wilde D B, Marrack P, Pierres A, Wall K A, Havran W, Otten G, Loken M R, Pierres M, Kappler J, Fitch F W. Characterization of the murine antigenic determinant, designated L3T4a. recognized by monoclonal antibody GKI. 5: expression opf L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983; 14: 29–56
  • Nawata Y, Stall A M, Herzenberg L A, Eugui E M, Allison A C. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5−- B lymphocytes. Int Immunol 1990; 2: 603–614
  • Snapper C M, Finkelman F D, Paul W E. Regulation of IgGl and IgE production by interleukin 4. Immunol Rev 1988; 102: 51–75
  • Theofilopoulos A N, Dixon F J. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
  • Conger J D, Pike B L, Nossal G JV. Clonal analysis of the anti-DNA repertoire of murine B lymphocytes. Proc Notl Acod Sci USA 1987; 84: 2931–2935
  • Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T. Age-associated increase in interleukin 6 in MRLbpr mice. Int Immunol 1991; 3: 273–278
  • Cyster J, Somoza C, Killeen N, Williams A F. Protein sequence and gene structure for mouse leukosialin (CD43). a T lymphocyte mucin without introns in the coding sequence. Eur J Immunol 1990; 20: 875–881
  • Carlsson S R, Fukuda M. Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. J Biol Chem 1986; 261: 12779–12786
  • Chatila T A, Geha R S. Phosphorylation of T cell membrane proteins by activators of protein kinase C. J Immunol 1988; 140: 4308–4314
  • Wiken M, Bjorck P, Axelsson B, Perlmann P. Enhancement of human Bcell proliferation by a monoclonal antibody to CD43. Scond J Immunol 1989; 29: 363–370
  • Suzuki N, Sakane T, Engleman E G. Anti-DNA antibody production by CD5+ and CD5−- B cells of patients with systemic lupus erythematosus. J Clin Invest 1990; 85: 238–247
  • Casali P, Burastero S E, Balow J E, Notkins A L. High affinity antibodies to ssDNA are produced by CD5– B cells in systemic lupus erythematosus patients. J Immunol 1989; 143: 34763483
  • Taki S, Hirose S, Kinoshita K, Nishimura H, Shimamura T, Hamuro J, Shirai T. Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody. Eur J Immunol 1992; 22: 987–992
  • Forster I, Gu H, Rajewsky K. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J 1988; 7: 3693–3703
  • Pennel C A, Mercolino T J, Grdina T A, Arnold L W, Haughton G, Clarke S H. Biased immunoglobulin variable gene expression by Ly-I B cells due to clonal selection. Eur J Immunol 1989; 19: 1289–1295
  • Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H, Shirai T. Requirement of H-2 heterozygosity for autoimmunity in (NZB×NZW) FI hybrid mice. Eur J Immunol 1986; 16: 1631–1633
  • Okada T, Takiura F, Tokushige K, Nozawa S, Kiyosawa T, Nakauchi H, Hirose S, Shirai T. Major histocompatibility complex controls clonal proliferation of CDS(Ly-I)+ B cells in H-2-congenic New Zealand mice: A model for B-cell chronic lym-phocytic leukemia and autoimmune disease. Eur J Immunol 1991; 21: 2743–2748
  • Wofsy D, Chiang N Y. Proliferation of Ly-l B cells in autoimmune NZB and (NZB×NZW) FI mice. Eur J Immunol 1987; 17: 809–814
  • Marion T N, Bothwell A LM, Briles D E, Janeway C A, Jr. IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. J Immunol 1989; 142: 4269–4214
  • Shlomchik M, Mascelli M, Shan H, Radic M Z, Pisetsky D, Marshak-Rothstein A, Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171: 265–297
  • Alarcón-Riquelme M E, Möller G, Fernández C. Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB×NZW) FI hybrid. Clin Immunol Immunopothol 1992; 62: 264–269

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.